• Norsk
  • English

January 2015

Vaccibody Granted Platform Patent in the US

Vaccibody AS is pleased to announce that the U.S. Patent Office has issued a patent covering the Vaccibody format which can be described as homodimeric modular constructs targeting vaccines to antigen presenting cells designed to increase the immune system’s antibody and T-cell responses. In December, the equivalent patent was granted by the European Patent Office.